The 2024 clinical practice guidelines on the pharmacological management of Behavioural and Psychological Symptoms of Dementia (BPSD) in the Arab world
Abstract Background Over 90% of individuals living with dementia experience behavioural and psychological symptoms of dementia, like agitation, anxiety, delusions, and sleep disturbances, which complicate care and place significant demands on healthcare systems. These guidelines are designed to meet...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2025-01-01
|
| Series: | Middle East Current Psychiatry |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s43045-024-00495-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832595051083988992 |
|---|---|
| author | Syed Ali Bokhari Tarik Qassem Dania Al-Ayyat Syed Fahad Javaid Hamed Al-Sinawi Walid Nasr |
| author_facet | Syed Ali Bokhari Tarik Qassem Dania Al-Ayyat Syed Fahad Javaid Hamed Al-Sinawi Walid Nasr |
| author_sort | Syed Ali Bokhari |
| collection | DOAJ |
| description | Abstract Background Over 90% of individuals living with dementia experience behavioural and psychological symptoms of dementia, like agitation, anxiety, delusions, and sleep disturbances, which complicate care and place significant demands on healthcare systems. These guidelines are designed to meet the unique needs of dementia care in the Arab world, where dementia rates are increasing due to an ageing population. Main body These clinical practice guidelines provide evidence-based guidance tailored to the Arab World, with a focus on minimising unnecessary psychotropic use in dementia. The guidelines advocate a multi-pronged strategy, prioritising non-pharmacological interventions which are often safer and align well with local values and caregiving practices. Pharmacological treatments are recommended only for severe cases where symptoms cause distress or pose a risk to the patient or others. The guidelines cover key medication classes with detailed recommendations on dosage, side effects, and monitoring. Conclusions By integrating culturally appropriate, evidence-based strategies, these guidelines aim to enhance dementia care quality, incorporate the perspectives of patients and caregivers, support healthcare professionals, and promote safer, more effective management of dementia across diverse healthcare settings in the region. |
| format | Article |
| id | doaj-art-73fbf07f257241329fb236a5621005ad |
| institution | Kabale University |
| issn | 2090-5416 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | SpringerOpen |
| record_format | Article |
| series | Middle East Current Psychiatry |
| spelling | doaj-art-73fbf07f257241329fb236a5621005ad2025-01-19T12:08:05ZengSpringerOpenMiddle East Current Psychiatry2090-54162025-01-0132112010.1186/s43045-024-00495-6The 2024 clinical practice guidelines on the pharmacological management of Behavioural and Psychological Symptoms of Dementia (BPSD) in the Arab worldSyed Ali Bokhari0Tarik Qassem1Dania Al-Ayyat2Syed Fahad Javaid3Hamed Al-Sinawi4Walid Nasr5Emirates Health Services, Al-Amal Psychiatric HospitalEmirates Health Services, Al-Amal Psychiatric HospitalEmirates Health Services, Al-Amal Psychiatric HospitalDepartment of Psychiatry, College of Medicine and Health Sciences, United Arab Emirates UniversityBehavioral Medicine Department, Sultan Qaboos University HospitalEmirates Health Services, Al-Amal Psychiatric HospitalAbstract Background Over 90% of individuals living with dementia experience behavioural and psychological symptoms of dementia, like agitation, anxiety, delusions, and sleep disturbances, which complicate care and place significant demands on healthcare systems. These guidelines are designed to meet the unique needs of dementia care in the Arab world, where dementia rates are increasing due to an ageing population. Main body These clinical practice guidelines provide evidence-based guidance tailored to the Arab World, with a focus on minimising unnecessary psychotropic use in dementia. The guidelines advocate a multi-pronged strategy, prioritising non-pharmacological interventions which are often safer and align well with local values and caregiving practices. Pharmacological treatments are recommended only for severe cases where symptoms cause distress or pose a risk to the patient or others. The guidelines cover key medication classes with detailed recommendations on dosage, side effects, and monitoring. Conclusions By integrating culturally appropriate, evidence-based strategies, these guidelines aim to enhance dementia care quality, incorporate the perspectives of patients and caregivers, support healthcare professionals, and promote safer, more effective management of dementia across diverse healthcare settings in the region.https://doi.org/10.1186/s43045-024-00495-6DementiaBehavioural and psychological symptoms of dementiaComplicationsPharmacotherapyPractice guidelinesArab world |
| spellingShingle | Syed Ali Bokhari Tarik Qassem Dania Al-Ayyat Syed Fahad Javaid Hamed Al-Sinawi Walid Nasr The 2024 clinical practice guidelines on the pharmacological management of Behavioural and Psychological Symptoms of Dementia (BPSD) in the Arab world Middle East Current Psychiatry Dementia Behavioural and psychological symptoms of dementia Complications Pharmacotherapy Practice guidelines Arab world |
| title | The 2024 clinical practice guidelines on the pharmacological management of Behavioural and Psychological Symptoms of Dementia (BPSD) in the Arab world |
| title_full | The 2024 clinical practice guidelines on the pharmacological management of Behavioural and Psychological Symptoms of Dementia (BPSD) in the Arab world |
| title_fullStr | The 2024 clinical practice guidelines on the pharmacological management of Behavioural and Psychological Symptoms of Dementia (BPSD) in the Arab world |
| title_full_unstemmed | The 2024 clinical practice guidelines on the pharmacological management of Behavioural and Psychological Symptoms of Dementia (BPSD) in the Arab world |
| title_short | The 2024 clinical practice guidelines on the pharmacological management of Behavioural and Psychological Symptoms of Dementia (BPSD) in the Arab world |
| title_sort | 2024 clinical practice guidelines on the pharmacological management of behavioural and psychological symptoms of dementia bpsd in the arab world |
| topic | Dementia Behavioural and psychological symptoms of dementia Complications Pharmacotherapy Practice guidelines Arab world |
| url | https://doi.org/10.1186/s43045-024-00495-6 |
| work_keys_str_mv | AT syedalibokhari the2024clinicalpracticeguidelinesonthepharmacologicalmanagementofbehaviouralandpsychologicalsymptomsofdementiabpsdinthearabworld AT tarikqassem the2024clinicalpracticeguidelinesonthepharmacologicalmanagementofbehaviouralandpsychologicalsymptomsofdementiabpsdinthearabworld AT daniaalayyat the2024clinicalpracticeguidelinesonthepharmacologicalmanagementofbehaviouralandpsychologicalsymptomsofdementiabpsdinthearabworld AT syedfahadjavaid the2024clinicalpracticeguidelinesonthepharmacologicalmanagementofbehaviouralandpsychologicalsymptomsofdementiabpsdinthearabworld AT hamedalsinawi the2024clinicalpracticeguidelinesonthepharmacologicalmanagementofbehaviouralandpsychologicalsymptomsofdementiabpsdinthearabworld AT walidnasr the2024clinicalpracticeguidelinesonthepharmacologicalmanagementofbehaviouralandpsychologicalsymptomsofdementiabpsdinthearabworld AT syedalibokhari 2024clinicalpracticeguidelinesonthepharmacologicalmanagementofbehaviouralandpsychologicalsymptomsofdementiabpsdinthearabworld AT tarikqassem 2024clinicalpracticeguidelinesonthepharmacologicalmanagementofbehaviouralandpsychologicalsymptomsofdementiabpsdinthearabworld AT daniaalayyat 2024clinicalpracticeguidelinesonthepharmacologicalmanagementofbehaviouralandpsychologicalsymptomsofdementiabpsdinthearabworld AT syedfahadjavaid 2024clinicalpracticeguidelinesonthepharmacologicalmanagementofbehaviouralandpsychologicalsymptomsofdementiabpsdinthearabworld AT hamedalsinawi 2024clinicalpracticeguidelinesonthepharmacologicalmanagementofbehaviouralandpsychologicalsymptomsofdementiabpsdinthearabworld AT walidnasr 2024clinicalpracticeguidelinesonthepharmacologicalmanagementofbehaviouralandpsychologicalsymptomsofdementiabpsdinthearabworld |